Bowman & Co S.C.
- SEC CIK
- 0001906275
- Latest filing
- Jan 23, 2026
EW holding history
Edwards Lifesciences Corp in every 13F filed by Bowman & Co S.C., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
EW overviewAll 13F holders of EWFull Q4 2025 holdings
- Shares (Q4 2025)
- 8,407
- Value
- $716.6K
- % of portfolio
- 0.3%
- Quarters held
- 17
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 8,407 | $716.6K | 0.3% | −20−0.2% | Reduced | Holders |
| Q3 2025 | 8,427 | $655.3K | 0.3% | −13−0.2% | Reduced | Holders |
| Q2 2025 | 8,440 | $660.0K | 0.3% | −5,138−37.8% | Reduced | Holders |
| Q1 2025 | 13,578 | $984.1K | 0.5% | +1,091+8.7% | Added | Holders |
| Q4 2024 | 12,487 | $924.3K | 0.5% | +148+1.2% | Added | Holders |
| Q3 2024 | 12,339 | $814.2K | 0.4% | +1,412+12.9% | Added | Holders |
| Q2 2024 | 10,927 | $1.01M | 0.6% | +993+10.0% | Added | Holders |
| Q1 2024 | 9,934 | $949.3K | 0.6% | −322−3.1% | Reduced | Holders |
| Q4 2023 | 10,256 | $782.0K | 0.5% | +830+8.8% | Added | Holders |
| Q3 2023 | 9,426 | $653.0K | 0.5% | +1,753+22.8% | Added | Holders |
| Q2 2023 | 7,673 | $723.8K | 0.5% | +192+2.6% | Added | Holders |
| Q1 2023 | 7,481 | $618.9K | 0.5% | +2,936+64.6% | Added | Holders |
| Q4 2022 | 4,545 | $339.1K | 0.3% | −1,620−26.3% | Reduced | Holders |
| Q3 2022 | 6,165 | $509.0K | 0.5% | +240+4.1% | Added | Holders |
| Q2 2022 | 5,925 | $563.0K | 0.5% | +270+4.8% | Added | Holders |
| Q1 2022 | 5,655 | $666.0K | 0.5% | +91+1.6% | Added | Holders |
| Q4 2021 | 5,564 | $722.0K | 0.6% | – | No prior filing | Holders |